Predictive Oncology Current Ratio 2010-2024 | POAI
Predictive Oncology current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Predictive Oncology Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-09-30 |
$0.01B |
$0.00B |
1.20 |
2024-06-30 |
$0.01B |
$0.01B |
1.49 |
2024-03-31 |
$0.01B |
$0.01B |
1.45 |
2023-12-31 |
$0.01B |
$0.00B |
2.55 |
2023-09-30 |
$0.01B |
$0.00B |
3.24 |
2023-06-30 |
$0.02B |
$0.00B |
4.24 |
2023-03-31 |
$0.02B |
$0.00B |
5.06 |
2022-12-31 |
$0.02B |
$0.00B |
6.02 |
2022-09-30 |
$0.03B |
$0.00B |
7.74 |
2022-06-30 |
$0.03B |
$0.00B |
10.56 |
2022-03-31 |
$0.03B |
$0.00B |
9.79 |
2021-12-31 |
$0.03B |
$0.00B |
9.09 |
2021-09-30 |
$0.04B |
$0.00B |
14.42 |
2021-06-30 |
$0.05B |
$0.00B |
14.16 |
2021-03-31 |
$0.03B |
$0.00B |
8.65 |
2020-12-31 |
$0.00B |
$0.01B |
0.16 |
2020-09-30 |
$0.00B |
$0.01B |
0.30 |
2020-06-30 |
$0.00B |
$0.02B |
0.30 |
2020-03-31 |
$0.00B |
$0.01B |
0.30 |
2019-12-31 |
$0.00B |
$0.01B |
0.07 |
2019-09-30 |
$0.00B |
$0.01B |
0.10 |
2019-06-30 |
$0.00B |
$0.01B |
0.12 |
2019-03-31 |
$0.00B |
$0.01B |
0.77 |
2018-12-31 |
$0.00B |
$0.00B |
0.40 |
2018-09-30 |
$0.00B |
$0.00B |
1.30 |
2018-06-30 |
$0.00B |
$0.00B |
3.14 |
2018-03-31 |
$0.00B |
$0.00B |
3.99 |
2017-12-31 |
$0.00B |
$0.00B |
2.54 |
2017-09-30 |
$0.00B |
$0.00B |
2.71 |
2017-06-30 |
$0.00B |
$0.00B |
3.45 |
2017-03-31 |
$0.01B |
$0.00B |
4.06 |
2016-12-31 |
$0.00B |
$0.00B |
1.66 |
2016-09-30 |
$0.00B |
$0.00B |
1.16 |
2016-06-30 |
$0.00B |
$0.00B |
1.72 |
2016-03-31 |
$0.00B |
$0.00B |
2.51 |
2015-12-31 |
$0.01B |
$0.00B |
3.55 |
2015-09-30 |
$0.01B |
$0.00B |
3.15 |
2015-06-30 |
$0.00B |
$0.01B |
0.08 |
2015-03-31 |
$0.00B |
$0.01B |
0.08 |
2014-12-31 |
$0.00B |
$0.01B |
0.10 |
2014-09-30 |
$0.00B |
$0.01B |
0.20 |
2014-06-30 |
$0.00B |
$0.00B |
0.18 |
2014-03-31 |
$0.00B |
$0.00B |
0.30 |
2013-12-31 |
$0.00B |
$0.00B |
0.11 |
2013-09-30 |
$0.00B |
$0.00B |
0.40 |
2013-06-30 |
$0.00B |
$0.00B |
0.11 |
2013-03-31 |
$0.00B |
$0.00B |
0.22 |
2012-12-31 |
$0.00B |
$0.00B |
0.07 |
2012-09-30 |
$0.00B |
$0.00B |
0.12 |
2012-06-30 |
$0.00B |
$0.00B |
0.09 |
2012-03-31 |
$0.00B |
$0.00B |
0.08 |
2011-12-31 |
$0.00B |
$0.00B |
0.13 |
2011-09-30 |
$0.00B |
$0.00B |
0.07 |
2011-06-30 |
$0.00B |
$0.00B |
0.05 |
2011-03-31 |
$0.00B |
$0.00B |
0.19 |
2010-12-31 |
$0.00B |
$0.00B |
0.01 |
2010-09-30 |
$0.00B |
$0.00B |
0.02 |
2010-06-30 |
$0.00B |
$0.00B |
0.04 |
2010-03-31 |
$0.00B |
$0.00B |
0.07 |
2009-12-31 |
$0.00B |
$0.00B |
0.10 |
2009-09-30 |
$0.00B |
$0.00B |
0.17 |
2009-06-30 |
$0.00B |
|
0.00 |
2009-03-31 |
$0.00B |
|
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.005B |
$0.002B |
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|